UCB Pharma Limited

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Patient Information Leaflet last updated on the eMC: 12/04/2011
PIL Tylex Effervescent

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 01/02/2011 and displayed until 12/04/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 18/11/2009 and displayed until 01/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Company name change or merger
Updated on 11/07/2008 and displayed until 18/11/2009
Reasons for adding or updating:
  • Change of manufacturer
Updated on 11/07/2008 and displayed until 11/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 16/01/2008 and displayed until 11/07/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/10/2007 and displayed until 16/01/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   paracetamol
   codeine phosphate hemihydrate